No Data
No Data
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. (NYSE:PFE) is a gift.Pfizer is looking to build on the success of its COVID-19 vaccine
Pfizer Options Spot-On: On May 14th, 100.96K Contracts Were Traded, With 3.07 Million Open Interest
On May 14th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 100.96K options for the day, of which put options accounted for 43.69% of the total transactions, and call o
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This growth would be primarily fueled by the expansion of ad
Express News | France received investment commitments totaling 15 billion euros from Microsoft, Amazon, Pfizer and others
NHS Introduces Pfizer's Tafamidis for ATTR-CM Treatment
Chengda Pharmaceutical (301201.SZ): No orders in progress from the Pfizer API factory
Gelonghui, May 14 | Chengda Pharmaceutical (301201.SZ) said on the investor interactive platform that currently, the company has no orders from the Pfizer API factory. Please refer to the company's announcement for the information to be disclosed.
No Data